Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | A simplified comorbidity index to predict mortality in allo-HCT recipients

Roni Shouval • 11 Feb 2021
TCT 2021
General

Comorbidity burden is a key consideration in determining risk in patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). In this interview, Roni Shouval, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the results of a single-center retrospective analysis evaluating the influence of comorbidities in patients undergoing transplantation. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

More from Roni Shouval

Deep learning-based profiling of CAR-T immune dynamics from routine peripheral blood smears
2:11
Deep learning-based profiling of CAR-T immune dynamics from routine peripheral blood smears
Roni Shouval • 23 Mar 2026
Treatment failure patterns in second-line versus third-line introduction of CAR-T therapy in LBCL
2:30
Treatment failure patterns in second-line versus third-line introduction of CAR-T therapy in LBCL
Roni Shouval • 7 Feb 2025
The incidence of atrial arrhythmias following CAR-T and the risk factors for this complication
1:21
The incidence of atrial arrhythmias following CAR-T and the risk factors for this complication
Roni Shouval • 7 Feb 2025
The mechanisms of cardiotoxicity following treatment with CAR-T
1:43
The mechanisms of cardiotoxicity following treatment with CAR-T
Roni Shouval • 7 Feb 2025

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals